Home
>
National Drug Code (NDC)
>
Diphenoxylate Hydrochloride and Atropine Sulfate
Diphenoxylate Hydrochloride and Atropine Sulfate - 49999-207-20 - (diphenoxylate hydrochloride and atropine sulfate)
Drug Information of Diphenoxylate Hydrochloride and Atropine Sulfate
| Product NDC: | 49999-207 |
| Proprietary Name: | Diphenoxylate Hydrochloride and Atropine Sulfate |
| Non Proprietary Name: | diphenoxylate hydrochloride and atropine sulfate |
| Active Ingredient(s): | .025; 2.5 mg/1; mg/1 & nbsp; diphenoxylate hydrochloride and atropine sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Diphenoxylate Hydrochloride and Atropine Sulfate
| Product NDC: | 49999-207 |
| Labeler Name: | Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA085762 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101130 |
Package Information of Diphenoxylate Hydrochloride and Atropine Sulfate
| Package NDC: | 49999-207-20 |
| Package Description: | 20 TABLET in 1 BOTTLE, PLASTIC (49999-207-20) |
NDC Information of Diphenoxylate Hydrochloride and Atropine Sulfate
| NDC Code | 49999-207-20 |
| Proprietary Name | Diphenoxylate Hydrochloride and Atropine Sulfate |
| Package Description | 20 TABLET in 1 BOTTLE, PLASTIC (49999-207-20) |
| Product NDC | 49999-207 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diphenoxylate hydrochloride and atropine sulfate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101130 |
| Marketing Category Name | ANDA |
| Labeler Name | Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC |
| Substance Name | ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
| Strength Number | .025; 2.5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Antidiarrheal [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
